tristearin has been researched along with Liver Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hyodo, I; Ishige, K; Noguchi, M; Sakashita, M; Sakashita, S; Sakata, A; Uesugi, N | 1 |
| Akentiev, AV; Besra, SE; Bikov, AG; Gajbhiye, RL; Guha, P; Jaisankar, P; Karmakar, G; Nag, K; Nahak, P; Noskov, BA; Panda, AK; Roy, B | 1 |
2 other study(ies) available for tristearin and Liver Neoplasms
| Article | Year |
|---|---|
An autopsy case of non-traumatic fat embolism syndrome.
Topics: Aged, 80 and over; Autopsy; Carcinoma, Hepatocellular; Embolism, Fat; Fatal Outcome; Humans; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Male; Triglycerides | 2017 |
Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Colonic Neoplasms; Drug Carriers; Drug Compounding; Drug Liberation; Glucosides; Humans; Lipids; Liver Neoplasms; Mice; Nanostructures; Oleic Acids; Particle Size; Polyethylene Glycols; Resorcinols; Solubility; Stomach Neoplasms; Triglycerides; Ultrasonic Waves | 2018 |